Drug Use Investigation of Gadovist
Phase of Trial: Phase IV
Latest Information Update: 14 May 2018
At a glance
- Drugs Gadobutrol (Primary)
- Indications Breast cancer; Vascular disorders
- Focus Adverse reactions
- Sponsors Bayer
- 04 May 2018 Status changed from active, no longer recruiting to completed.
- 29 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 26 Sep 2017 Planned primary completion date changed from 15 Sep 2017 to 15 Sep 2018.